These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31552817)

  • 41. Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay.
    Ginocchio CC; Chapin K; Smith JS; Aslanzadeh J; Snook J; Hill CS; Gaydos CA
    J Clin Microbiol; 2012 Aug; 50(8):2601-8. PubMed ID: 22622447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Validation of the APTIMA Combo 2 assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in SurePath liquid-based pap test samples taken with different collection devices.
    Chernesky M; Jang D; Smieja M; Portillo E; Ewert R; Pritchard C; MacEachern D; Doucette C; MacDonald A; Kapala J; Sumner J; Hill C
    Sex Transm Dis; 2009 Sep; 36(9):581-3. PubMed ID: 19661842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Head-to-head comparison of second-generation nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae on urine samples from female subjects and self-collected vaginal swabs.
    Chernesky M; Jang D; Gilchrist J; Hatchette T; Poirier A; Flandin JF; Smieja M; Ratnam S
    J Clin Microbiol; 2014 Jul; 52(7):2305-10. PubMed ID: 24696024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estimating the positive predictive value of opportunistic population testing for gonorrhoea as part of the English Chlamydia Screening Programme.
    Fowler T; Edeghere O; Inglis N; Bradshaw S
    Int J STD AIDS; 2013 Mar; 24(3):185-91. PubMed ID: 23514834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chlamydia trachomatis infection positivity rates determined by nucleic acid amplification test in patients of hospitals in the northeastern region of Ukraine.
    Belozorov A; Fedets O; Chastii T; Milutina E; Sokol O; Grigorova R; Unuchko S
    Int J STD AIDS; 2017 Dec; 28(14):1405-1409. PubMed ID: 28583015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening asymptomatic adolescent men for Chlamydia trachomatis in school-based health centers using urine-based nucleic acid amplification tests.
    Joffe A; Rietmeijer CA; Chung SE; Willard N; Chapin JB; Lloyd LV; Waterfield GA; Ellen JM; Gaydos C
    Sex Transm Dis; 2008 Nov; 35(11 Suppl):S19-23. PubMed ID: 18716568
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of Nucleic Acid Amplification Testing for Diagnosis of Extragenital Sexually Transmitted Infections.
    Cosentino LA; Danby CS; Rabe LK; Macio I; Meyn LA; Wiesenfeld HC; Hillier SL
    J Clin Microbiol; 2017 Sep; 55(9):2801-2807. PubMed ID: 28679521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of replacing the existing diagnostic strategy for Neisseria gonorrhoeae and Chlamydia trachomatis infections with sole molecular testing of urine specimens in a sexually transmitted infection clinic setting.
    Ho MK; Lo JY; Lo AC; Cheng FK; Chan FK
    Sex Transm Infect; 2009 Sep; 85(5):322-5. PubMed ID: 19406739
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of three nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens.
    Gaydos CA; Theodore M; Dalesio N; Wood BJ; Quinn TC
    J Clin Microbiol; 2004 Jul; 42(7):3041-5. PubMed ID: 15243057
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of pooled ocular and vaginal swabs by the Cepheid GeneXpert CT/NG assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae compared to the GenProbe Aptima Combo 2 Assay.
    Dize L; West SK; Mkocha H; Quinn TC; Gaydos CA
    Diagn Microbiol Infect Dis; 2015 Feb; 81(2):102-4. PubMed ID: 25497459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic methodologies for chlamydia screening in females aged 15 to 25 years from private insurance claims data in the United States, 2001 to 2005.
    Owusu-Edusei K; Bohm MK; Kent CK
    Sex Transm Dis; 2009 Jul; 36(7):419-21. PubMed ID: 19556935
    [No Abstract]   [Full Text] [Related]  

  • 52. Evaluation of the APTIMA Combo 2 Assay using self-administered vaginal swabs for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
    Crucitti T; De Deken B; Smet H; Cuylaerts V; Abdellati S; Vuylsteke B
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):385-6. PubMed ID: 23598167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gonococcal NAATs: what is the current state of play in England and Wales?
    Benzie A; Alexander S; Gill N; Greene L; Thomas S; Ison C
    Int J STD AIDS; 2010 Apr; 21(4):246-8. PubMed ID: 20378894
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-volume workflow and performance comparisons for Chlamydia trachomatis and Neisseria gonorrhoeae testing using automated molecular platforms.
    Frontzek A; Aretzweiler G; Winkens D; Duncan D; Marlowe EM
    BMC Infect Dis; 2019 Sep; 19(1):797. PubMed ID: 31510949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in pharyngeal and rectal specimens using the BD Probetec ET system, the Gen-Probe Aptima Combo 2 assay and culture.
    Ota KV; Tamari IE; Smieja M; Jamieson F; Jones KE; Towns L; Juzkiw J; Richardson SE
    Sex Transm Infect; 2009 Jun; 85(3):182-6. PubMed ID: 19126571
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Performance of the Gen-Probe AMPLIFIED Chlamydia Trachomatis Assay in detecting Chlamydia trachomatis in endocervical and urine specimens from women and urethral and urine specimens from men attending sexually transmitted disease and family planning clinics.
    Ferrero DV; Meyers HN; Schultz DE; Willis SA
    J Clin Microbiol; 1998 Nov; 36(11):3230-3. PubMed ID: 9774570
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplification: identification of urinary substances associated with inhibition and removal of inhibitory activity.
    Mahony J; Chong S; Jang D; Luinstra K; Faught M; Dalby D; Sellors J; Chernesky M
    J Clin Microbiol; 1998 Nov; 36(11):3122-6. PubMed ID: 9774550
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of flocked and aptima swabs and two specimen transport media in the aptima combo 2 assay.
    Li J; Jang D; Gilchrist J; Smieja M; Ewert R; MacRitchie C; Chernesky M
    J Clin Microbiol; 2014 Oct; 52(10):3808-9. PubMed ID: 25122855
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective comparison of cell cultures and nucleic acid amplification tests for laboratory diagnosis of Chlamydia trachomatis Infections.
    Jespersen DJ; Flatten KS; Jones MF; Smith TF
    J Clin Microbiol; 2005 Oct; 43(10):5324-6. PubMed ID: 16208009
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and particularly Trichomonas vaginalis diagnosed using US FDA-approved Aptima molecular tests and evaluation of conventional routine diagnostic tests in Ternopil, Ukraine.
    Boiko I; Golparian D; Krynytska I; Unemo M
    APMIS; 2019 Sep; 127(9):627-634. PubMed ID: 31225920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.